Amy Pate1, Jan Lowery2, Kristin Kilbourn3, Patrick J Blatchford4, Monica McNulty4, Betsy Risendal5,6. 1. Preventive Medicine Residency, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA. 2. Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA. 3. Department of Psychology, University of Colorado Denver, Denver, CO, USA. 4. Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO, USA. 5. Department of Community and Behavioral Health, Colorado School of Public Health, 13001 E. 17th Place, Bldg 500, MS F538, Aurora, CO, 80045, USA. betsy.risendal@cuanschutz.edu. 6. University of Colorado Comprehensive Cancer Center, Aurora, CO, USA. betsy.risendal@cuanschutz.edu.
Abstract
PURPOSE: Colorectal cancer (CRC) is the third most common cancer in the USA. The objective of this study was to compare quality of life (QoL) across long-term colorectal cancer survivors and unaffected matched controls while adjusting for comorbidities. METHODS: The National Cancer Institute (NCI)-funded Colon Cancer Family Registry (CCFR) was used to randomly select and recruit CRC survivors (≥ 5 years from diagnosis) and matched controls for a cross-sectional survey. Nine geographically diverse sites in the USA from the CCFR participated in the study. Telephone interviews were conducted using computer-assisted methods to assess QoL. RESULTS: A total of 403 cases and 401 controls were included in the final sample. Unadjusted comparison revealed no significant difference between CRC survivors and controls with respect to measures of fatigue, social, emotional, functional, and physical well-being. Multivariate logistic regression revealed that case status had a significant negative influence on colorectal cancer-specific QoL measures. Higher comorbidity indices had a significant negative influence on overall QoL regardless of case status. CONCLUSIONS: Quality of life among long-term CRC survivors is similar to control subjects, with the exception of worse CRC-specific QoL measures. Higher comorbidity indices were independently associated with poor QoL for both cases and controls. IMPLICATIONS FOR CANCER SURVIVORS: Survivors and healthcare providers should be aware that long-term QoL is comparable to the general population; however, there is potential that digestive tract-specific issues may persist.
PURPOSE:Colorectal cancer (CRC) is the third most common cancer in the USA. The objective of this study was to compare quality of life (QoL) across long-term colorectal cancer survivors and unaffected matched controls while adjusting for comorbidities. METHODS: The National Cancer Institute (NCI)-funded Colon Cancer Family Registry (CCFR) was used to randomly select and recruit CRC survivors (≥ 5 years from diagnosis) and matched controls for a cross-sectional survey. Nine geographically diverse sites in the USA from the CCFR participated in the study. Telephone interviews were conducted using computer-assisted methods to assess QoL. RESULTS: A total of 403 cases and 401 controls were included in the final sample. Unadjusted comparison revealed no significant difference between CRC survivors and controls with respect to measures of fatigue, social, emotional, functional, and physical well-being. Multivariate logistic regression revealed that case status had a significant negative influence on colorectal cancer-specific QoL measures. Higher comorbidity indices had a significant negative influence on overall QoL regardless of case status. CONCLUSIONS: Quality of life among long-term CRC survivors is similar to control subjects, with the exception of worse CRC-specific QoL measures. Higher comorbidity indices were independently associated with poor QoL for both cases and controls. IMPLICATIONS FOR CANCER SURVIVORS: Survivors and healthcare providers should be aware that long-term QoL is comparable to the general population; however, there is potential that digestive tract-specific issues may persist.
Entities:
Keywords:
Colon cancer; Colorectal cancer; Global quality of life; Long-term survivorship; Quality of life
Authors: Britni R Belcher; Dong-Woo Kang; Alexandra G Yunker; Christina M Dieli-Conwright Journal: Curr Oncol Rep Date: 2022-07-13 Impact factor: 5.945
Authors: Kaisa Lehtomäki; Hanna P Stedt; Emerik Osterlund; Timo Muhonen; Leena-Maija Soveri; Päivi Halonen; Tapio K Salminen; Juha Kononen; Raija Kallio; Annika Ålgars; Eetu Heervä; Annamarja Lamminmäki; Aki Uutela; Arno Nordin; Juho Lehto; Tiina Saarto; Harri Sintonen; Pirkko-Liisa Kellokumpu-Lehtinen; Raija Ristamäki; Bengt Glimelius; Helena Isoniemi; Pia Osterlund Journal: Cancers (Basel) Date: 2022-03-28 Impact factor: 6.639
Authors: Victoria M White; Karolina Lisy; Andrew Ward; Eli Ristevski; Melanie Clode; Kate Webber; Jon Emery; Maarten J Ijzerman; Nina Afshar; Jeremy Millar; Peter Gibbs; Sue Evans; Michael Jefford Journal: Support Care Cancer Date: 2022-03-12 Impact factor: 3.359